Monopar Therapeutics Inc. Common Stock ($0.001 par value per share) Capital on Demand™ Sales AgreementMonopar Therapeutics • April 20th, 2022 • Pharmaceutical preparations • New York
Company FiledApril 20th, 2022 Industry JurisdictionMonopar Therapeutics Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with JonesTrading Institutional Services LLC (the “Agent”), as follows: